Neurocrine Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

thSAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the 44 Annual J.P. Morgan Healthcare Conference at 9:45 a.m. Pacific Time on Monday, January 12, 2026, in San Francisco. Kyle Gano, Chief Executive Officer, will present at the conference. The live presentation will be webcast and can be accessed on Neurocrine Biosciences' website under Investors at www.neurocrine.com. A replay of the presentation will be available on the website approximately one hour aft ...